News

Chinese pharmaceutical company forms alliance with American CRO.

Direction from regulatory agencies would help eradicate wasteful 100 percent source data verification.

A 2010 survey conducted by the Tufts Center for the Study of Drug Development (Tufts CSDD) finds that sponsor companies are allocating resources, modifying organizational structures, and increasing investment in the development of personalized medicines (i.e., tailoring of medical treatment and healthcare delivery based on individual patient characteristics including genetic, molecular, and imaging).

Cover

News from the Orphan Drug workshop.

The recent shutdown of the R&D facility should signify a warning to the British science community.

<-- -->

INFORMATION TECHNOLOGY : A Risk-Based Approach for Computer Systems Validation SITES : Trial Monitoring - Source Document Verification REGULATORY : FDA's Guidance on Patient-Reported Outcomes ALSO IN THIS ISSUE : FDA's Oversight Capabilities Increased, Influenza Warning Issued, Cloud Computing: A Reality?, Guidance Says Focus on the Patient

eClinical Trials Collaboration Challenge Integrated Technology Manage Trial Master Files via Investigative Portals Directory

Automated eTMF solutions reduce costs, improve productivity, and enhance data management.

Asia, Latin American, and Eastern Europe are increasingly attractive geographies in which to conduct clinical research.

Though they are the largest minority in the country, Hispanics remain underrepresented.